When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
LPCN - Lipocine stock rises premarket after being granted two U.S. patents
Lipocine Inc.
Lipocine (NASDAQ:LPCN) on Tuesday said it had been granted two U.S. patents for its central nervous system and liver programs. LPCN stock +6% to $0.88 in premarket trading. The U.S. Patent and Trademark Office granted LPCN patent 11,337,987 for "Compositions and Methods for Treating Central Nervous System Disorders". The USPTO also granted patent 11,370,811 for "Testosterone Dodecanoate Compositions and Methods of Preparation and Use".